Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on Nov 20, 2026 >>   ABB 6915 [ -0.62 ]ACC 1276.45 [ 0.65 ]AMBUJA CEM 399.3 [ 0.58 ]ASIAN PAINTS 2603.35 [ 0.37 ]AXIS BANK 1447 [ 2.05 ]BAJAJ AUTO 10778 [ -0.34 ]BANKOFBARODA 286.6 [ 0.39 ]BHARTI AIRTE 2155.5 [ 0.39 ]BHEL 433 [ -0.23 ]BPCL 312 [ 1.46 ]BRITANIAINDS 4890 [ 0.42 ]CIPLA 1414.95 [ -0.07 ]COAL INDIA 390 [ -0.51 ]COLGATEPALMO 1760.6 [ -0.81 ]DABUR INDIA 394 [ 0.77 ]DLF 783.5 [ 2.14 ]DRREDDYSLAB 1390.5 [ -0.54 ]GAIL 191.45 [ -0.21 ]GRASIM INDS 3102.4 [ -0.07 ]HCLTECHNOLOG 1337 [ 0.41 ]HDFC BANK 845.25 [ 3.02 ]HEROMOTOCORP 5523 [ -0.59 ]HIND.UNILEV 2054 [ -0.96 ]HINDALCO 930.3 [ 2.34 ]ICICI BANK 1641 [ 2.22 ]INDIANHOTELS 911.55 [ 2.22 ]INDUSINDBANK 1005 [ 8.88 ]INFOSYS 1096.4 [ 0.54 ]ITC LTD 298.8 [ -0.73 ]JINDALSTLPOW 1125.35 [ 4.31 ]KOTAK BANK 516 [ 3.08 ]L&T 4201 [ -0.10 ]LUPIN 2010 [ 0.55 ]MAH&MAH 3541.5 [ 0.89 ]MARUTI SUZUK 13990.3 [ 2.88 ]MTNL 24.28 [ -2.18 ]NESTLE 1326 [ 1.58 ]NIIT 69.47 [ -0.97 ]NMDC 69 [ 1.16 ]NTPC 320.8 [ -1.29 ]ONGC 223.5 [ -0.45 ]PNB 155.2 [ -0.13 ]POWER GRID 268.5 [ 1.70 ]RIL 1375.1 [ 0.37 ]SBI 1164.95 [ 0.60 ]SESA GOA 237.6 [ -2.38 ]SHIPPINGCORP 256.7 [ 2.87 ]SUNPHRMINDS 1885.1 [ -0.94 ]TATA CHEM 639.15 [ -1.64 ]TATA GLOBAL 1155 [ 1.18 ]TATA MOTORS 266.05 [ 1.04 ]TATA STEEL 177.75 [ -1.69 ]TATAPOWERCOM 340 [ 0.00 ]TCS 2375 [ 1.21 ]TECH MAHINDR 1742 [ 1.10 ]ULTRATECHCEM 12926.4 [ 2.75 ]UNITED SPIRI 1461 [ -0.27 ]WIPRO 185.5 [ 0.60 ]ZEETELEFILMS 71.4 [ -0.07 ] BSE NSE
You can view the entire text of Notes to accounts of the company for the latest year

BSE: 532150ISIN: INE681B01017INDUSTRY: Hospitals & Medical Services

BSE   ` 362.55   Open: 360.35   Today's Range 360.00
368.80
+1.90 (+ 0.52 %) Prev Close: 360.65 52 Week Range 293.50
542.70
Year End :2026-03 

Q. Provisions, contingent liabilities and contingent assets

A provision is recognised when the Company has a present obligation as a result of past event and it is probable that an
outflow of resources will be required to settle the obligation, in respect of which a reliable estimate can be made. If the
effect of the time value of money is material, provisions are discounted using a current pre-tax rate that reflects, when
appropriate, the risks specific to the liability. When discounting is used, the increase in the provision due to the passage
of time is recognised as a finance cost.

Contingent liability is disclosed in the case of a present obligation arising from a past event when it is not probable that
an outflow of resources embodying economic benefits will be required to settle the obligation or a possible obligation,
unless the probability of outflow in settlement is remote.

R. Financial instruments

A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity
instrument of another entity.

Initial Recognition and measurement

On initial recognition, all the financial assets and liabilities are recognized at their fair value plus or minus, in the case of a
financial asset or financial liability not at fair value through profit or loss, transaction costs that are directly attributable to
the acquisition or issue of the financial asset or financial liability.

Subsequent measurement

(i) Financial assets carried at amortised cost

A financial asset is subsequently measured at amortised cost if it is held within a business model whose objective
is to hold the asset in order to collect contractual cash flows and the contractual terms of the financial asset give
rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount
outstanding.

(ii) Financial assets at fair value through other comprehensive income (FVTOCI)

A financial asset is subsequently measured at fair value through other comprehensive income if it is held within a
business model whose objective is achieved by both collecting contractual cash flows and selling financial assets
and the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments
of principal and interest on the principal amount outstanding.

(iii) Financial assets at fair value through profit or loss (FVTPL)

A financial asset which is not classified in any of the above categories is subsequently measured at fair value
through profit or loss.

(iv) Financial liabilities

The financial liabilities are subsequently carried at amortized cost using the effective interest method. For trade and
other payables maturing within one year from the balance sheet date, the carrying amounts approximate fair value
due to the short-term maturity of these instruments.

Fair value measurement of financial instruments

The fair value of financial instruments is determined using the valuation techniques that are appropriate in the
circumstances and for which sufficient data are available to measure fair value, maximising the use of relevant observable
inputs and minimising the use of unobservable inputs.

Based on the three level fair value hierarchy, the methods used to determine the fair value of financial assets and liabilities
include quoted market price, discounted cash flow analysis and valuation certified by the external valuer.

I n case of financial instruments where the carrying amount approximates fair value due to the short maturity of those
instruments, carrying amount is considered as fair value.

Derecognition of financial instrument

A financial asset is derecognized when the contractual rights to the cash flows from the financial asset expire or it transfers
the financial asset and the transfer qualifies for derecognition under Ind AS 109. A financial liability is derecognized when
the obligation specified in the contract is discharged or cancelled or expired.

Equity instruments

Equity shares issued by the Company are classified as equity. Incremental costs directly attributable to the issuance of
new ordinary shares and share options are recognized as a deduction from equity, net of any tax effects.

S. Recent pronouncements

Ministry of Corporate Affairs (“MCA”) notifies new standards or amendments to the existing standards under Companies
(Indian Accounting Standards) Rules as issued from time to time.

I n May 2025, MCA notified amendments to Ind AS 21 - The Effects of Changes in Foreign Exchange Rates, applicable
w.e.f. April 01,2025. The Company has reviewed the amendment and based on its evaluation has determined that it
does not have any significant impact in its financial statements.

In August 2025, MCA notified the following amendments to:

1 I nd AS 1, Presentation of Financial Statements, applicable w.e.f. April 01, 2025 - The amendment relates to
classification of liabilities as current or non-current and non-current liabilities with covenants. In the context of
classifying a liability as current, it removes the requirement of existence of a right to defer settlement for at least 12
months after the reporting date and instead requires that the said right should exist on the reporting date and have
substance. The amendment also introduces guidance on classification of liabilities with covenants. The Company
has no impact of these amendments in its classification criteria of current and non-current liabilities.

2 I nd AS 7, Statement of Cash Flows and Ind AS 107, Financial Instruments: Disclosures, applicable w.e.f. April 01,
2025 - The amendment in Ind AS 7 requires to inform users of financial statements of the existence of supplier
finance arrangements and explain the nature of the arrangements, the carrying amount of liabilities and the range
of payment due dates. Ind AS 107 has been amended to add supplier finance arrangements as a factor that may
cause concentration of liquidity risk. The Company has reviewed the amendment and based on its evaluation has
determined that it does not have any impact in its financial statements.

3 I nd AS 12, International Tax Reform - Pillar Two Model Rules applicable immediately - The amendments provide
a temporary mandatory relief from deferred tax accounting for top-up tax and disclose that they have applied the
relief. This relief is immediate and applies retrospectively. The Company has reviewed the amendment and based
on its evaluation has determined that it does not have any impact in its financial statements.

NOTES ON ACCOUNTS

A. Estimated amount of contracts remaining to be executed on capital account and not provided for is ' 10.18 Crore

(Previous year ' 3.12 Crore).

B. Contingent Liability

i) Claims against the Company not acknowledged as debt ' 105.27 Crore (Previous Year ' 88.75 Crore) and interest
thereon, if any. This represents suits filed against the Company and the consultant doctors. Based on the facts
and circumstances, possibility of any of the claims resulting in a major financial loss to the Company is remote.
Notwithstanding above, the Company is adequately insured to mitigate the possibility of any loss.

ii) Bank guarantees and Letter of Credits (LC) outstanding on account of stores / spares and medical equipment
amounting to ' 0.34 Crore (Previous year ' 22.35 Crore)

iii) In respect of:

C. On a Public Interest Litigation (PIL) regarding free treatment in the hospital the Hon'ble Delhi High Court vide its order
dated September 22, 2009 has held that free treatment provided by the hospital as per the terms of lease deed with
Government of National Capital Territory of Delhi shall be inclusive of medicines and consumables. In response to the
said order the company filed a Special Leave Petition in the Hon'ble Supreme Court for appropriate directions. The
Hon'ble Supreme Court of India has admitted the Special Leave Petition and passed an interim order on November 30,
2009. In pursuance of the interim order, the Hospital has been providing free treatment to the patients referred by the
Govt. of NCT of Delhi. The hospital is charging for medicines and medical consumables from patients referred by the
Govt. of NCT of Delhi for free treatment in the Hospital in accordance with the directions of the Hon'ble Supreme Court of
India. The matter is currently under consideration by the Hon'ble Supreme Court. The Company has remained compliant
with the applicable requirements under the lease. As the matter remains sub judice, any potential financial implications,
if any, will be assessed upon final determination by the Hon'ble Supreme Court.

D. i) Under the terms of the agreement between the Government of NCT of Delhi and the Company, the Hospital

building has been constructed on the land leased out to the Company by the Government of NCT of Delhi. The
Government of NCT of Delhi has met the expenditure to the extent of ' 15.48 Crore out of IMCL Building fund
account (funds earmarked for the project) together with the interest thereon for construction of building while the
balance amount of the cost of the building was borne by the Company. The cost of the building and net carrying
amount in the books of account as on March 31,2026 is ' 206.78 Crore and ' 127.16 Crore respectively. The
ownership of the building between Government of NCT of Delhi and the Company will be decided at a future date
keeping in view of the lease agreement

ii) Other expenses include ' 12/- (previous year ' 12/-) towards leasehold ground rent as per the terms of agreement
between Govt. of NCT of Delhi and the Company.

E. Employee benefits

Defined benefit plan
Gratuity (Funded)

The Company provides to the eligible employees, defined benefit plans in the form of gratuity. The gratuity plan provides
for a lump sum payment to vested employees at retirement, death while in employment or on termination of employment
of an amount equivalent to 15 days' salary payable for each completed year of service. Vesting occurs upon completion
of five continuous years of service.

Foreign currency risk

The fluctuation in foreign currency exchange rates may have potential impact on the Statement of Profit and Loss
and equity, where any transaction references more than one currency or where assets/liabilities are denominated in a
currency other than the functional currency.

Considering the economic environment in which the Company operates, its operations are subject to risks arising from
fluctuations in exchange rates. The risks primarily relate to fluctuations in US$ against the functional currency (?) of the
Company.

F. Financial Risk Management

The principal financial assets of the Company include loans, trade and other receivables, and cash and bank balances
that derive directly from its operations. The principal financial liabilities of the Company include overdraft, cash credit
facility, trade and other payables and the main purpose of these financial liabilities is to finance the day to day operations
of the Company.

The Company is exposed to market risk, credit risk and liquidity risk. The Company's senior management oversees the
management of these risks and advises on financial risks and the appropriate financial risk governance framework for the
Company. The risks which the Company is exposed to and policies and framework adopted by the Company to manage
these risks are explained as under:

Market Risk

Market risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in
market prices. Company is exposed to interest rate risk as its Market risk.

Interest Rate Risk

I nterest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of
changes in market interest rates. The Company's exposure to the risk of changes in market interest rates relates primarily
to the Company's debt obligations in the form of overdraft and cash credit facility with floating interest rates.

As the Company has no significant interest-bearing assets, the income and operating cash flows are substantially
independent of changes in market interest rates.

Liquidity Risk

The financial liabilities of the Company include loans and borrowings, trade and other payables. The Company's principal
sources of liquidity are cash and cash equivalents and the cash flow that is generated from operations.

The below is the detail of contractual maturities of the financial liabilities of the Company at the end of each reporting
period:

Credit Risk

Credit risk refers to the risk of default on its obligation by the counterparty resulting in a financial loss. The exposure
to the credit risk at the reporting date is primarily from trade receivables which are typically unsecured. Majority of the
Company's transactions are earned in cash or cash equivalents. The trade receivables comprise mainly of receivables
from Insurance Companies, Corporate customers and Government Undertakings. The Insurance Companies are
required to maintain minimum reserve levels and the Corporate Customers are enterprises with high credit ratings.
Accordingly, the Company's exposure to credit risk in relation to trade receivables is low.

The Company assesses the creditworthiness of the customers internally to whom services are rendered on credit terms
in the normal course of business. The credit limit of each customer is defined in accordance with this assessment.
Outstanding customer receivables are regularly monitored.

The Company recognizes loss allowances using the expected credit loss (ECL) model for the financial assets which are
not fair valued through profit or loss. Loss allowance for trade receivables with no significant financing component is
measured at an amount equal to lifetime ECL. For all other financial assets, expected credit losses are measured at an
amount equal to the 12-month ECL, unless there has been a significant increase in credit risk from initial recognition in
which case those are measured at lifetime ECL.

K. The Ministry of Micro, Small and Medium Enterprises has issued an office memorandum dated August 26, 2008 which
recommends that the Micro and Small Enterprises should mention in their correspondence with its customers the
Entrepreneurs Memorandum Number as allocated after filing of the Memorandum. Accordingly, the disclosure in respect
of the amounts payable to such enterprises as at March 31,2026 has been made in the financial statements based on
information received and available with the Company. Further in view of the management, the impact of interest, if any,
that may be payable in accordance with the provisions of the Micro, Small and Medium Enterprises Development Act,
2006 (‘The MSMED Act') is not expected to be material. The Company has not received any claim for interest from any
supplier during the year.

$ Key Management Personnel are covered under the Company’s gratuity and leave encashment scheme along with
the other employee benefits of the Company. The gratuity/ leave encashment liability is determined for all employees
based on an independent actuarial valuation. The specific amount of gratuity/ leave encashment for Key Management
Personnel cannot be ascertained separately and accordingly the same has not been included in respective employees.

M. The Basic earning per share (EPS) disclosed in the Statement of Profit and Loss has been calculated by dividing the
net profit for the year ended March 31,2026 attributable to equity shareholders by the weighted average number of
equity shares outstanding during the said financial year. The net profit attributable to equity share holders is ' 183.62
Crore (Previous Year ' 160.99 Crore) and the weighted average number of equity share is 91,673,000 (Previous Year
91,673,000) for this purpose.

N. In accordance with Ind AS - 36 on Impairment of Assets, the Company has assessed whether any indications with regard
to impairment of any assets exists as on the Balance Sheet date. Based on such assessment, it has been ascertained
that there are no such indications and thereby no formal estimate of the recoverable amount has been made.

O. As per Section 135 of the Companies Act, 2013, a company, meeting the applicability threshold, needs to spend at
least 2% of its average net profit for the immediately preceding three financial years on corporate social responsibility
(CSR) activities. The areas for CSR activities are promoting education and healthcare. The Company has fully spent the
required amount towards Corporate Social Responsibility (CSR) and there are no unspent CSR amount for the year
requiring a transfer to a Fund specified in Schedule VII to the Companies Act or special account in compliance with the
provision of sub-section (6) of section 135 of the said Act.

P. As per the “management approach” defined in Ind AS 108, Operating segments are to be reported in a manner
consistent with the internal reporting provided to the Chief Operating Decision Maker (CODM). The Company operates
in a single segment i.e. Healthcare and hence, does not have any additional disclosures to be made under Ind AS 108
on Operating Segments.